Sanofi SA Inhaber EO 2

€ 86,94
Opdateret 03:34:07
ISIN: FR0000120578

I dag

Market closed

Marked er lukket, åbner klokken 09:00

	27 feb	Toujeo® Receives Positive Opinion from the European Regulatory Authorities

	26 feb	Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®

	23 feb	Sanofi : Information concerning the total number of voting rights and shares

	20 feb	Sanofi: INFORMATION CONCERNING THE COMPENSATION OF MR. OLIVIER BRANDICOURT

	19 feb	Sanofi : Sanofi Appoints Olivier Brandicourt as Chief Executive Officer

	18 feb	Sanofi : Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases

	17 feb	Sanofi : ENGAGE Randomized Clinical Trial Evaluating Cerdelga® (eliglustat) for Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association

	05 feb	Sanofi: Sanofi delivers Business EPS(1) growth of 7.3% at CER in 2014

	03 feb	Sanofi : Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.

	26 jan	Sanofi : Sanofi and Regeneron Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

For lav Flash Player version